Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Adam Weiss and James Crichton are Bullish on $WMB and $ST

Adam Weiss and James Crichton founded Scout Capital Management in 1999. The pair spoke at the Value Investing Congress on Tuesday. In their presentation, they discussed two value stocks – Williams Companies (WMB) and Sensata Technologies Holding N.v. (ST).

Williams Companies, Inc. (NYSE:WMB)

Weiss and Crichton are Bullish on Williams Cos. $WMB

Adam Weiss and James Crichton bought a stake in WMB worth more than $180 million in the second quarter. They say the stock is trading at $24 a share while they see a $47 a share upside. The pair say it is a quality stock. Its long distance pipeline is very attractive. It has value on its own but the high cost of building new pipelines mean that barriers to entry for other companies is high. While there are risks, like the fact that it is capes intensive, they think WMB will have no problem reaching its 7-10% EBITDA as most of its business is fee based. Weiss and Crichton also expect that WMB will increase its dividend yield in January.

Sensata is Also a Favorite of the Scout Capital Pair

Adam Weiss and James Crichton also like Sensata Technologies. They are forecasting growth of 10% per annum over the next few years for the safety products company. The company’s products are essential for safety and environmental preservation, and for users the switching cost is very high. They say that there is no alternative for customers who want to switch after the product is installed. Also, because of the nature of its products, WMB has low labor and production costs, citing the fact that for WMB every $1 in EBITDA translates to 70 cents in profit.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!